150 related articles for article (PubMed ID: 34079371)
1. USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels.
Duan B; Wang C; Liu Z; Yang X
Cancer Manag Res; 2021; 13():4181-4189. PubMed ID: 34079371
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ubiquitin specific peptidase 8 is effective against 5-fluorouracil resistance in colon cancer via suppressing EGFR and EGFR-mediated signaling pathways.
Xi C; Gong Z; Ye H; Cao L; Yu J
Histol Histopathol; 2024 Feb; 39(2):251-261. PubMed ID: 37222451
[TBL] [Abstract][Full Text] [Related]
3. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
[TBL] [Abstract][Full Text] [Related]
4. USP8 is a novel target for overcoming gefitinib resistance in lung cancer.
Byun S; Lee SY; Lee J; Jeong CH; Farrand L; Lim S; Reddy K; Kim JY; Lee MH; Lee HJ; Bode AM; Won Lee K; Dong Z
Clin Cancer Res; 2013 Jul; 19(14):3894-904. PubMed ID: 23748694
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation.
Sun J; Shen D; Gao Y; Zheng Y; Zhao L; Maa M; Liu H; Chen X
Onco Targets Ther; 2020; 13():7973-7984. PubMed ID: 32848421
[TBL] [Abstract][Full Text] [Related]
6. USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K/AKT Signaling Pathway.
Sun J; Shen D; Zheng Y; Ren H; Liu H; Chen X; Gao Y
Onco Targets Ther; 2020; 13():9941-9952. PubMed ID: 33116578
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion.
Jing X; Chen Y; Chen Y; Shi G; Lv S; Cheng N; Feng C; Xin Z; Zhang L; Wu J
Cancer Manag Res; 2020; 12():2185-2194. PubMed ID: 32273758
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of USP8 inhibits prostate cancer cell growth, proliferation, and metastasis and promotes docetaxel's activity by suppressing the NF-kB signaling pathway.
Islam MT; Chen FZ; Chen HC; Wahid A
Front Oncol; 2022; 12():923270. PubMed ID: 36338727
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells by Inducing Apoptosis.
Jeong CH
J Cancer Prev; 2015 Mar; 20(1):57-63. PubMed ID: 25853104
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-Specific Peptidase 8 Modulates Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis in Breast Cancer by Stabilizing Estrogen Receptor Alpha.
Zheng L; Yang Q; Li C; Xu G; Yuan Q; Hou J; Wu G
J Oncol; 2023; 2023():8483325. PubMed ID: 36644233
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics.
Islam MT; Chen F; Chen H
Arch Biochem Biophys; 2021 Apr; 701():108811. PubMed ID: 33600786
[TBL] [Abstract][Full Text] [Related]
12. The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation.
Meijer IM; Kerperien J; Sotoca AM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Apr; 25(4):919-30. PubMed ID: 23333852
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth.
Long Y; Hu Z; Yang D; Wang F; Zhao C; Zhang Y; Zhang Y; Ma H; Lv H
Open Life Sci; 2023; 18(1):20220562. PubMed ID: 36816802
[TBL] [Abstract][Full Text] [Related]
14. The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis.
Corno C; D'Arcy P; Bagnoli M; Paolini B; Costantino M; Carenini N; Corna E; Alberti P; Mezzanzanica D; Colombo D; Linder S; Arrighetti N; Perego P
Front Cell Dev Biol; 2022; 10():1055067. PubMed ID: 36578788
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Husni RE; Sakashita S; Takeuchi T; Noguchi M
Pathol Int; 2017 Jun; 67(6):292-301. PubMed ID: 28544031
[TBL] [Abstract][Full Text] [Related]
16. USP8 modulates ubiquitination of LRIG1 for Met degradation.
Oh YM; Lee SB; Choi J; Suh HY; Shim S; Song YJ; Kim B; Lee JM; Oh SJ; Jeong Y; Cheong KH; Song PH; Kim KA
Sci Rep; 2014 May; 4():4980. PubMed ID: 24828152
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8.
Wu X; Yen L; Irwin L; Sweeney C; Carraway KL
Mol Cell Biol; 2004 Sep; 24(17):7748-57. PubMed ID: 15314180
[TBL] [Abstract][Full Text] [Related]
18. USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP
Jeong M; Lee EW; Seong D; Seo J; Kim JH; Grootjans S; Kim SY; Vandenabeele P; Song J
Oncogene; 2017 Jan; 36(4):458-470. PubMed ID: 27321185
[TBL] [Abstract][Full Text] [Related]
19. Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.
Fattore L; Marra E; Pisanu ME; Noto A; de Vitis C; Belleudi F; Aurisicchio L; Mancini R; Torrisi MR; Ascierto PA; Ciliberto G
J Transl Med; 2013 Jul; 11():180. PubMed ID: 23890105
[TBL] [Abstract][Full Text] [Related]
20. Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status.
Das I; Wilhelm M; Höiom V; Franco Marquez R; Costa Svedman F; Hansson J; Tuominen R; Egyhàzi Brage S
Cell Death Dis; 2019 Sep; 10(9):663. PubMed ID: 31506424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
